Rivard Paul 4
4 · MyMD Pharmaceuticals, Inc. · Filed Dec 8, 2022
Insider Transaction Report
Form 4
Rivard Paul
EVP of Operations, GC
Transactions
- Purchase
Common stock
2022-12-08$1.53/sh+10,000$15,300→ 225,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.53, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc., any security holder of MyMD Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.